News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,629 Results
Type
Article (8025)
Company Profile (147)
Press Release (481457)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166751)
Career Advice (304)
Deals (25742)
Drug Delivery (7)
Drug Development (52881)
Employer Resources (14)
FDA (9761)
Job Trends (8572)
News (238210)
Policy (17898)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (12)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (1)
Academia (502)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33157)
ALS (122)
Alzheimer's disease (1016)
Antibody-drug conjugate (ADC) (336)
Approvals (10495)
Artificial intelligence (382)
ASCO (160)
Autoimmune disease (259)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (61)
BIOSECURE Act (1)
Biosimilars (126)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (30)
Bladder cancer (149)
Brain cancer (36)
Breast cancer (553)
Cancer (4130)
Cardiovascular disease (247)
Career advice (245)
Career pathing (1)
CAR-T (196)
CDC (2)
CDMO (36)
Celiac Disease (3)
Cell therapy (535)
Cervical cancer (37)
Clinical research (48626)
Collaboration (1382)
Commercialization (34)
Compensation (1666)
Complete response letters (36)
COVID-19 (777)
CRISPR (76)
C-suite (873)
Cystic fibrosis (89)
Data (6707)
Denatured (4)
Depression (109)
Dermatology (105)
Diabetes (388)
Diagnostics (4285)
Digital health (43)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (176)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (176)
Earnings (74494)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89245)
Executive appointments (744)
Eye disease (7)
FDA (12740)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (25)
Funding (1010)
Gene editing (141)
Generative AI (15)
Gene therapy (360)
GLP-1 (319)
Government (953)
Grass and pollen (2)
Guidances (288)
Healthcare (9448)
Hematology (115)
HIV (60)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (82)
Immunology and inflammation (114)
Immuno-oncology (75)
Indications (188)
Infectious disease (986)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (275)
Interviews (41)
IPO (12402)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (91)
Layoffs (59)
Legal (5195)
Licensing (65)
Liver cancer (47)
Longevity (28)
Lung cancer (588)
Lung diease (11)
Lymphoma (282)
Machine learning (30)
Management (3)
Manufacturing (631)
Marketing (24)
MASH (131)
Medical affairs (2)
Medical device (8728)
Medtech (8930)
Mergers & acquisitions (14490)
Metabolic disorders (791)
mRNA (82)
Multiple sclerosis (118)
Multispecific (3)
NASH (4)
Netherlands (4)
Neurodegenerative disease (249)
Neuropsychiatric disorders (41)
Neuroscience (1990)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (845)
Obesity (246)
Opinion (10)
Ovarian cancer (184)
Pain (195)
Pancreatic cancer (236)
Parkinson's disease (219)
Partnered (12)
Patents (532)
Patient advocacy (3)
Patient recruitment (550)
Patient selection (55)
Peanut (34)
People (41586)
Peptides (24)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (15706)
Phase 2 (21747)
Phase 3 (14666)
Pipeline (9019)
Policy (20)
Postmarket research (1570)
Preclinical (6619)
Press Release (34)
Prostate cancer (211)
Psychedelics (12)
Radiopharmaceuticals (205)
Rare diseases (640)
Real estate (3026)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15253)
Reports (26)
Research institute (596)
Resumes & cover letters (45)
Rett syndrome (47)
RNA editing (9)
RSV (51)
Schizophrenia (111)
Series A (179)
Series B (128)
Service/supplier (5)
Sickle cell disease (70)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2021)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (56)
Switzerland (2)
Tariffs (2)
Vaccines (361)
Venture capital (18)
Weight loss (79)
Wet AMD (3)
Women's health (101)
Date
Today (151)
Last 7 days (702)
Last 30 days (2381)
Last 365 days (19230)
2026 (17232)
2025 (19254)
2024 (22991)
2023 (26539)
2022 (34590)
2021 (37169)
2020 (33469)
2019 (23263)
2018 (17472)
2017 (18765)
2016 (17921)
2015 (24264)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20333)
Location
Africa (233)
Alabama (81)
Alaska (2)
Arizona (331)
Arkansas (12)
Asia (18097)
Australia (2129)
California (13374)
Canada (3446)
China (594)
Colorado (549)
Connecticut (469)
Delaware (236)
Europe (24859)
Florida (1989)
Georgia (420)
Hawaii (3)
Idaho (46)
Illinois (803)
India (66)
Indiana (339)
Iowa (19)
Japan (466)
Kansas (105)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1317)
Massachusetts (8755)
Michigan (325)
Minnesota (623)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (139)
New Hampshire (61)
New Jersey (2941)
New Mexico (12)
New York (3121)
North Carolina (1414)
North Dakota (4)
Northern California (6795)
Ohio (311)
Oklahoma (15)
Oregon (17)
Pennsylvania (2491)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5591)
Tennessee (131)
Texas (2208)
United States (43249)
Utah (405)
Vermont (1)
Virginia (169)
Washington D.C. (39)
Washington State (1019)
West Virginia (1)
Wisconsin (84)
Wyoming (1)
489,629 Results for "maxcyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MaxCyte to Participate in Three Upcoming November 2026 Investor Conferences
October 28, 2026
·
1 min read
Press Releases
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
September 23, 2026
·
2 min read
Press Releases
MaxCyte Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Total Revenue Guidance
November 10, 2026
·
17 min read
Press Releases
MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
October 14, 2026
·
7 min read
Press Releases
MaxCyte to Acquire Akron Bio, Expanding its Offerings Across Cell Therapy Manufacturing and Expecting to Nearly Double Revenue Base
November 10, 2026
·
14 min read
Press Releases
MaxCyte Reports Second Quarter 2026 Financial Results
August 13, 2026
·
15 min read
Press Releases
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 11, 2026
September 13, 2026
·
2 min read
Press Releases
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
July 16, 2026
·
1 min read
Press Releases
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
July 21, 2026
·
2 min read
Press Releases
MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies
August 19, 2026
·
2 min read
1 of 48,963
Next
